48 research outputs found
Identifying Drug Effects via Pathway Alterations using an Integer Linear Programming Optimization Formulation on Phosphoproteomic Data
Understanding the mechanisms of cell function and drug action is a major endeavor in
the pharmaceutical industry. Drug effects are governed by the intrinsic properties of the
drug (i.e., selectivity and potency) and the specific signaling transduction network of the
host (i.e., normal vs. diseased cells). Here, we describe an unbiased, phosphoproteomicbased
approach to identify drug effects by monitoring drug-induced topology alterations.
With the proposed method, drug effects are investigated under several conditions on a
cell-type specific signaling network. First, starting with a generic pathway made of
logical gates, we build a cell-type specific map by constraining it to fit 13 key
phopshoprotein signals under 55 experimental cases. Fitting is performed via a
formulation as an Integer Linear Program (ILP) and solution by standard ILP solvers; a
procedure that drastically outperforms previous fitting schemes. Then, knowing the cell
topology, we monitor the same key phopshoprotein signals under the presence of drug
and cytokines and we re-optimize the specific map to reveal the drug-induced topology
alterations. To prove our case, we make a pathway map for the hepatocytic cell line
HepG2 and we evaluate the effects of 4 drugs: 3 selective inhibitors for the Epidermal
Growth Factor Receptor (EGFR) and a non selective drug. We confirm effects easily
predictable from the drugsâ main target (i.e. EGFR inhibitors blocks the EGFR pathway)
but we also uncover unanticipated effects due to either drug promiscuity or the cellâs
specific topology. An interesting finding is that the selective EGFR inhibitor Gefitinib is
able to inhibit signaling downstream the Interleukin-1alpha (IL-1α) pathway; an effect
that cannot be extracted from binding affinity based approaches. Our method represents
an unbiased approach to identify drug effects on a small to medium size pathways and
is scalable to larger topologies with any type of signaling perturbations (small molecules,
3
RNAi etc). The method is a step towards a better picture of drug effects in pathways,
the cornerstone in identifying the mechanisms of drug efficacy and toxicity
Identification of signaling pathways related to drug efficacy in hepatocellular carcinoma via integration of phosphoproteomic, genomic and clinical data
Hepatocellular Carcinoma (HCC) is one of the leading causes of death worldwide, with only a handful of treatments effective in unresectable HCC. Most of the clinical trials for HCC using new generation interventions (drug-targeted therapies) have poor efficacy whereas just a few of them show some promising clinical outcomes [1]. This is amongst the first studies where the mode of action of some of the compounds extensively used in clinical trials is interrogated on the phosphoproteomic level, in an attempt to build predictive models for clinical efficacy. Signaling data are combined with previously published gene expression and clinical data within a consistent framework that identifies drug effects on the phosphoproteomic level and translates them to the gene expression level. The interrogated drugs are then correlated with genes differentially expressed in normal versus tumor tissue, and genes predictive of patient survival. Although the number of clinical trial results considered is small, our approach shows potential for discerning signaling activities that may help predict drug efficacy for HCC.National Institutes of Health (U.S.) (Grant U54-CA119267)National Institutes of Health (U.S.) (Grant R01-CA96504
Combined logical and data-driven models for linking signalling pathways to cellular response
Background
Signalling pathways are the cornerstone on understanding cell function and predicting cell behavior. Recently, logical models of canonical pathways have been optimised with high-throughput phosphoproteomic data to construct cell-type specific pathways. However, less is known on how signalling pathways can be linked to a cellular response such as cell growth, death, cytokine secretion, or transcriptional activity.
Results
In this work, we measure the signalling activity (phosphorylation levels) and phenotypic behavior (cytokine secretion) of normal and cancer hepatocytes treated with a combination of cytokines and inhibitors. Using the two datasets, we construct "extended" pathways that integrate intracellular activity with cellular responses using a hybrid logical/data-driven computational approach. Boolean logic is used whenever a priori knowledge is accessible (i.e., construction of canonical pathways), whereas a data-driven approach is used for linking cellular behavior to signalling activity via non-canonical edges. The extended pathway is subsequently optimised to fit signalling and behavioural data using an Integer Linear Programming formulation. As a result, we are able to construct maps of primary and transformed hepatocytes downstream of 7 receptors that are capable of explaining the secretion of 22 cytokines.
Conclusions
We developed a method for constructing extended pathways that start at the receptor level and via a complex intracellular signalling pathway identify those mechanisms that drive cellular behaviour. Our results constitute a proof-of-principle for construction of "extended pathways" that are capable of linking pathway activity to diverse responses such as growth, death, differentiation, gene expression, or cytokine secretion.Marie Curie International Reintegration Grants (MIRG-14-CT-2007-046531)Vertex Pharmaceuticals IncorporatedBundesministerium fĂŒr Wissenschaft und Forschung (HepatoSys)Massachusetts Institute of Technology (Rockwell International Career Development Professorship)Bundesministerium fĂŒr Wissenschaft und Forschung (HepatoSys 0313081D
Revisiting the Training of Logic Models of Protein Signaling Networks with a Formal Approach based on Answer Set Programming
A fundamental question in systems biology is the construction and training to
data of mathematical models. Logic formalisms have become very popular to model
signaling networks because their simplicity allows us to model large systems
encompassing hundreds of proteins. An approach to train (Boolean) logic models
to high-throughput phospho-proteomics data was recently introduced and solved
using optimization heuristics based on stochastic methods. Here we demonstrate
how this problem can be solved using Answer Set Programming (ASP), a
declarative problem solving paradigm, in which a problem is encoded as a
logical program such that its answer sets represent solutions to the problem.
ASP has significant improvements over heuristic methods in terms of efficiency
and scalability, it guarantees global optimality of solutions as well as
provides a complete set of solutions. We illustrate the application of ASP with
in silico cases based on realistic networks and data
Non Linear Programming (NLP) Formulation for Quantitative Modeling of Protein Signal Transduction Pathways
Modeling of signal transduction pathways plays a major role in understanding cells' function and predicting cellular response. Mathematical formalisms based on a logic formalism are relatively simple but can describe how signals propagate from one protein to the next and have led to the construction of models that simulate the cells response to environmental or other perturbations. Constrained fuzzy logic was recently introduced to train models to cell specific data to result in quantitative pathway models of the specific cellular behavior. There are two major issues in this pathway optimization: i) excessive CPU time requirements and ii) loosely constrained optimization problem due to lack of data with respect to large signaling pathways. Herein, we address both issues: the former by reformulating the pathway optimization as a regular nonlinear optimization problem; and the latter by enhanced algorithms to pre/post-process the signaling network to remove parts that cannot be identified given the experimental conditions. As a case study, we tackle the construction of cell type specific pathways in normal and transformed hepatocytes using medium and large-scale functional phosphoproteomic datasets. The proposed Non Linear Programming (NLP) formulation allows for fast optimization of signaling topologies by combining the versatile nature of logic modeling with state of the art optimization algorithms.National Institutes of Health (U.S.) (Grant P50-GM068762)National Institutes of Health (U.S.) (Grant R24-DK090963)United States. Army Research Office (Grant W911NF-09-0001)German Research Foundation (Grant GSC 111
Translational Systems Pharmacology-Based Predictive Assessment of Drug-Induced Cardiomyopathy
Drug-induced cardiomyopathy contributes to drug attrition. We compared two pipelines of predictive modeling: (1) applying elastic net (EN) to differentially expressed genes (DEGs) of drugs; (2) applying integer linear programming (ILP) to construct each drugâs signaling pathway starting from its targets to downstream proteins, to transcription factors, and to its DEGs in human cardiomyocytes, and then subjecting the genes/proteins in the drugsâ signaling networks to EN regression. We classified 31 drugs with availability of DEGs into 13 toxic and 18 nontoxic drugs based on a clinical cardiomyopathy incidence cutoff of 0.1%. The ILP-augmented modeling increased prediction accuracy from 79% to 88% (sensitivity: 88%; specificity: 89%) under leave-one-out cross validation. The ILP-constructed signaling networks of drugs were better predictors than DEGs. Per literature, the microRNAs that reportedly regulate expression of our six top predictors are of diagnostic value for natural heart failure or doxorubicin-induced cardiomyopathy. This translational predictive modeling might uncover potential biomarkers
Translational systems pharmacologyâbased predictive assessment of drugâinduced cardiomyopathy
Peer Reviewedhttps://deepblue.lib.umich.edu/bitstream/2027.42/142916/1/psp412272.pdfhttps://deepblue.lib.umich.edu/bitstream/2027.42/142916/2/psp412272_am.pd
A Network-Based Multi-Target Computational Estimation Scheme for Anticoagulant Activities of Compounds
BACKGROUND: Traditional virtual screening method pays more attention on predicted binding affinity between drug molecule and target related to a certain disease instead of phenotypic data of drug molecule against disease system, as is often less effective on discovery of the drug which is used to treat many types of complex diseases. Virtual screening against a complex disease by general network estimation has become feasible with the development of network biology and system biology. More effective methods of computational estimation for the whole efficacy of a compound in a complex disease system are needed, given the distinct weightiness of the different target in a biological process and the standpoint that partial inhibition of several targets can be more efficient than the complete inhibition of a single target. METHODOLOGY: We developed a novel approach by integrating the affinity predictions from multi-target docking studies with biological network efficiency analysis to estimate the anticoagulant activities of compounds. From results of network efficiency calculation for human clotting cascade, factor Xa and thrombin were identified as the two most fragile enzymes, while the catalytic reaction mediated by complex IXa:VIIIa and the formation of the complex VIIIa:IXa were recognized as the two most fragile biological matter in the human clotting cascade system. Furthermore, the method which combined network efficiency with molecular docking scores was applied to estimate the anticoagulant activities of a serial of argatroban intermediates and eight natural products respectively. The better correlation (râ=â0.671) between the experimental data and the decrease of the network deficiency suggests that the approach could be a promising computational systems biology tool to aid identification of anticoagulant activities of compounds in drug discovery. CONCLUSIONS: This article proposes a network-based multi-target computational estimation method for anticoagulant activities of compounds by combining network efficiency analysis with scoring function from molecular docking
A Boolean Approach to Linear Prediction for Signaling Network Modeling
The task of the DREAM4 (Dialogue for Reverse Engineering Assessments and Methods) âPredictive signaling network modelingâ challenge was to develop a method that, from single-stimulus/inhibitor data, reconstructs a cause-effect network to be used to predict the protein activity level in multi-stimulus/inhibitor experimental conditions. The method presented in this paper, one of the best performing in this challenge, consists of 3 steps: 1. Boolean tables are inferred from single-stimulus/inhibitor data to classify whether a particular combination of stimulus and inhibitor is affecting the protein. 2. A cause-effect network is reconstructed starting from these tables. 3. Training data are linearly combined according to rules inferred from the reconstructed network. This method, although simple, permits one to achieve a good performance providing reasonable predictions based on a reconstructed network compatible with knowledge from the literature. It can be potentially used to predict how signaling pathways are affected by different ligands and how this response is altered by diseases